245 related articles for article (PubMed ID: 9574528)
1. Ultraviolet light-induced immune tolerance is mediated via the Fas/Fas-ligand system.
Schwarz A; Grabbe S; Grosse-Heitmeyer K; Roters B; Riemann H; Luger TA; Trinchieri G; Schwarz T
J Immunol; 1998 May; 160(9):4262-70. PubMed ID: 9574528
[TBL] [Abstract][Full Text] [Related]
2. Dendritic cells are resistant to apoptosis through the Fas (CD95/APO-1) pathway.
Ashany D; Savir A; Bhardwaj N; Elkon KB
J Immunol; 1999 Nov; 163(10):5303-11. PubMed ID: 10553053
[TBL] [Abstract][Full Text] [Related]
3. Induction of specific T cell tolerance by Fas ligand-expressing antigen-presenting cells.
Zhang HG; Su X; Liu D; Liu W; Yang P; Wang Z; Edwards CK; Bluethmann H; Mountz JD; Zhou T
J Immunol; 1999 Feb; 162(3):1423-30. PubMed ID: 9973398
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of tolerance induced by transforming growth factor-beta-treated antigen-presenting cells: CD8 regulatory T cells inhibit the effector phase of the immune response in primed mice through a mechanism involving Fas ligand.
Kosiewicz MM; Alard P; Liang S; Clark SL
Int Immunol; 2004 May; 16(5):697-706. PubMed ID: 15096489
[TBL] [Abstract][Full Text] [Related]
5. Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectively.
Hashimoto W; Osaki T; Okamura H; Robbins PD; Kurimoto M; Nagata S; Lotze MT; Tahara H
J Immunol; 1999 Jul; 163(2):583-9. PubMed ID: 10395644
[TBL] [Abstract][Full Text] [Related]
6. Dendritic cells undergo rapid apoptosis in vitro during antigen-specific interaction with CD4+ T cells.
Matsue H; Edelbaum D; Hartmann AC; Morita A; Bergstresser PR; Yagita H; Okumura K; Takashima A
J Immunol; 1999 May; 162(9):5287-98. PubMed ID: 10228004
[TBL] [Abstract][Full Text] [Related]
7. Role of Fas/Fas ligand-mediated apoptosis in murine contact hypersensitivity.
Xu B; Bulfone-Paus S; Aoyama K; Yu S; Huang P; Morimoto K; Matsushita T; Takeuchi T
Int Immunopharmacol; 2003 Jul; 3(7):927-38. PubMed ID: 12810350
[TBL] [Abstract][Full Text] [Related]
8. Vaccination of apoptotic Fas ligand-expressing tumors decreased antitumor responses by enhanced production of immunosuppressive cytokines.
Wada A; Tada Y; Shimozato O; Takiguchi Y; Tatsumi K; Kuriyama T; Tagawa M
Anticancer Res; 2005; 25(1A):299-303. PubMed ID: 15816551
[TBL] [Abstract][Full Text] [Related]
9. Fas ligand (CD95L) and B7 expression on dendritic cells provide counter-regulatory signals for T cell survival and proliferation.
Lu L; Qian S; Hershberger PA; Rudert WA; Lynch DH; Thomson AW
J Immunol; 1997 Jun; 158(12):5676-84. PubMed ID: 9190916
[TBL] [Abstract][Full Text] [Related]
10. Induction of antitumor immunity with Fas/APO-1 ligand (CD95L)-transfected neuroblastoma neuro-2a cells.
Shimizu M; Fontana A; Takeda Y; Yagita H; Yoshimoto T; Matsuzawa A
J Immunol; 1999 Jun; 162(12):7350-7. PubMed ID: 10358186
[TBL] [Abstract][Full Text] [Related]
11. Effect of IL-12 on immune suppression and suppressor cell induction by ultraviolet radiation.
Schmitt DA; Owen-Schaub L; Ullrich SE
J Immunol; 1995 May; 154(10):5114-20. PubMed ID: 7730617
[TBL] [Abstract][Full Text] [Related]
12. Fas/Fas ligand interactions are involved in ultraviolet-B-induced human lymphocyte apoptosis.
Caricchio R; Reap EA; Cohen PL
J Immunol; 1998 Jul; 161(1):241-51. PubMed ID: 9647230
[TBL] [Abstract][Full Text] [Related]
13. Activation-induced T cell death: resistance or susceptibility correlate with cell surface fas ligand expression and T helper phenotype.
Oberg HH; Lengl-Janssen B; Kabelitz D; Janssen O
Cell Immunol; 1997 Oct; 181(1):93-100. PubMed ID: 9344501
[TBL] [Abstract][Full Text] [Related]
14. Fas/Apo-1 (CD95)-mediated apoptosis of neutrophils with Fas ligand (CD95L)-expressing tumors is crucial for induction of inflammation by neutrophilic polymorphonuclear leukocytes associated with antitumor immunity.
Shimizu M; Fontana A; Takeda Y; Yoshimoto T; Tsubura A; Matsuzawa A
Cell Immunol; 2001 Jan; 207(1):41-8. PubMed ID: 11161452
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide sensitizes tumor cells to dendritic cell-mediated apoptosis, uptake, and cross-presentation.
Huang J; Tatsumi T; Pizzoferrato E; Vujanovic N; Storkus WJ
Cancer Res; 2005 Sep; 65(18):8461-70. PubMed ID: 16166326
[TBL] [Abstract][Full Text] [Related]
16. Involvement of doxorubicin-induced Fas expression in the antitumor effect of doxorubicin on Lewis lung carcinoma in vivo.
Yoshimoto Y; Kawada M; Ikeda D; Ishizuka M
Int Immunopharmacol; 2005 Feb; 5(2):281-8. PubMed ID: 15652759
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms of immune-mediated lysis of murine renal cancer: differential contributions of perforin-dependent versus Fas-mediated pathways in lysis by NK and T cells.
Sayers TJ; Brooks AD; Lee JK; Fenton RG; Komschlies KL; Wigginton JM; Winkler-Pickett R; Wiltrout RH
J Immunol; 1998 Oct; 161(8):3957-65. PubMed ID: 9780164
[TBL] [Abstract][Full Text] [Related]
18. Anti-CD3 induces bi-phasic apoptosis in murine intestinal epithelial cells: possible involvement of the Fas/Fas ligand system in different T cell compartments.
Miura N; Yamamoto M; Fukutake M; Ohtake N; Iizuka S; Ishige A; Sasaki H; Fukuda K; Yamamoto T; Hayakawa S
Int Immunol; 2005 May; 17(5):513-22. PubMed ID: 15778290
[TBL] [Abstract][Full Text] [Related]
19. Dissociation of T cell anergy from apoptosis by blockade of Fas/Apo-1 (CD95) signaling.
Hargreaves RG; Borthwick NJ; Gilardini Montani MS; Piccolella E; Carmichael P; Lechler RI; Akbar AN; Lombardi G
J Immunol; 1997 Apr; 158(7):3099-107. PubMed ID: 9120262
[TBL] [Abstract][Full Text] [Related]
20. CD40 ligand inhibits Fas/CD95-mediated apoptosis of human blood-derived dendritic cells.
Koppi TA; Tough-Bement T; Lewinsohn DM; Lynch DH; Alderson MR
Eur J Immunol; 1997 Dec; 27(12):3161-5. PubMed ID: 9464801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
